Update on in vitro cytotoxicity assays for drug development

Expert Opinion on Drug Discovery

Volumn 3, Issue 6, 2008, Pages 655-669

  Niles, Andrew L ^a   Moravec, Richard A ^a   Riss, Terry L ^a  

^a PROMEGA CORPORATION   (United States)

Author keywords

Apoptosis; Cytostasis; Cytotoxicity; Fluorescence; High throughput; Luminescence; Multi parametric; Multiplex; Necrosis; Resazurin; Tetrazolium; Viability

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ADENOSINE TRIPHOSPHATE; ADENYLATE KINASE; FIREFLY LUCIFERASE; GLYCERALDEHYDE 3 PHOSPHATE; LACTATE DEHYDROGENASE; OXIDOREDUCTASE; PROTEINASE; REAGENT; RESAZURIN; TETRAZOLIUM;

BIOLUMINESCENCE; CELL ASSAY; CELL DEATH; CELL METABOLISM; CELL VIABILITY; CONCENTRATION RESPONSE; COST EFFECTIVENESS ANALYSIS; CULTURE MEDIUM; CYTOTOXICITY TEST; DATA ANALYSIS; DRUG CYTOTOXICITY; DRUG RESEARCH; ENZYME ANALYSIS; ENZYME RELEASE; FLUORESCENCE ANALYSIS; HIGH THROUGHPUT SCREENING; HUMAN; IN VITRO STUDY; INCUBATION TIME; INTERMETHOD COMPARISON; NONHUMAN; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY;

EID: 45949085183     PISSN: 17460441     EISSN: None     Source Type: Journal    
DOI: 10.1517/17460441.3.6.655     Document Type: Review

References (115)

1. Horvath S. Cytotoxicity of drugs and diverse chemical agents to cell cultures. Toyicology 1980;16:59-66
2. Myers M. Direct measurement of cell numbers in microtitre plate cultures using the fluorescent dye SYBR green I. J Immunol Methods 1998;212:99-103
3. Cook J, Mitchell J. Viability measurements in mammalian cell systems. Anal Biochem 1989;179:1-7
4. Borenfruend E, Puerner J. Toxicity determined in vitro by morphological alterations and neutral red absorption. Toxicol Lett 1985;24:119-24
5. Riss T, Moravec R. Use of multiple assay endpoints to investigate the effects of incubation time, dose of toxin, and plating density in cell-based cytotoxicity assays. Assay Drug Dev Technol 2004;2:51-62
6. Leist M, Jaattela M. Four deaths and a funeral: from caspases to alternative mechanisms. Nat Rev 2001;2:1-10
7. Bolt M, Card J, Racz W, et al. Disruption of mitochondrial function and cellular ATP levels by amiodarone and N-desethylamiodarone in initiation of amiodarone-induced pulmonary cytotoxicity. J Pharmacol Exp Ther 2001;298:1280
8. Chen Q, Cederbaum A. Cytotoxicity and apoptosis produced by cytochrome P450 2E1 in Hep G2 cells. Mol Pharmacol 1998;53:638
9. Hantz H, Young L, Martin K. Physiologically attainable concentrations of lycopene induce mitochondrial apoptosis in LNCaP human prostate cancer cells. Exp Biol Med 2005;230:171-9
10. Rixie O, Fojo T. Is cell death a critical end point for anticancer therapies or is cytostasis sufficient? Clin Cancer Res 2007;13:7280-7
11. Buxser S, Vroegop S. Calculating the probability of detection for inhibitors in enzymatic or binding reactions in high throughput screening. Anal Biochem 2005;340:1-13
12. Inglese J, Auld D, Jadhav A, et al. Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries. Proc Natl Acad Sci USA 2006;103:11473-8
13. Xia M, Huang R, Witt K, et al. Compound cytotoxicity profilling using quantitative high-throughput screening. Environ Health Perspect 2008;116:284-91
14. Fink S, Cookson B. Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infect Immun 2005;73:1907-16
15. Majno G, Joris I. Apoptosis, oncosis, and necrosis: an overview of cell death. Am J Pathol 1995;146:3-15
16. Wyllie A, Kerr J, Currie A. Cell death: the significance of apoptosis. Int Rev Cytol 1980;68:251-306
17. Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immun Methods 1983;65:55-63
18. Gonzalez P, Tarloff J. Evaluation of hepatic subcellular fractions for Alamar Blue and MTT reductase activity. Toxicol In Vitro 2001;15:257-9
19. Alley M, Scudiero D, Monks A, et al. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 1988;48:589-601
20. Scudiero D, Shoemaker R, Paull K, et al. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res 1988;48:4827-33
21. Paull K, Shoemaker R, Boyd M, et al. The synthesis of XTT: a new tetrazolium reagent that is bioreducible to a water-soluble formazan. J Heterocyclic Chem 1988;25:911
22. Roehm N, Rodgers G, Hatfield S, et al. An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium, salt XTT. J Immunol Methods 1991;142:257-65
23. Barltrop J, Owen T. 5-(3-carboxymethoxyphenyl)-2-(4,5-dimethylthiazoly)-3-(4-sulfophenyl) tetrazolium, inner salt (MTS) and related analogs of 3-(4,5-dimethylthiazolyl)-2,5-diphenyltetrazolium bromide (MTT) reducing to purple water-soluble formazans as cell-viability indicators. Bioorg Med Chem Lett 1991;1:611-4
24. Cory A, Owen T, Barltrop J, et al. Use of an aqueous soluble tetrazolium/ formazan assay for cell growth assays in culture. Cancer Commun 1991;3:207-12
25. Ishiyama M, Masanobu S, Sasamoto K. A new sutfonated tetrazolium salt that produces a highly water soluble formazan dye. Chem Pharm Bull 1993;41:1118-22
26. Ramsdell G, Johnson W, Evans F. Investigation of resazurin as an indicator of the sanitary condition of milk. J Dairy Sci 1935;18:705-17
27. Alamar Biosciences Laboratory. Antibiotic and cytotoxic drug susceptibility assays using resazurin and poising agents. US5501959; 1996
28. O'Brien J, Wilson I, Orton T, et al. Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur J Biochem 2000;267:5421-6
29. Page B, Page M, Noel C. A new fluorometric assay for cytotoxicity measurements in vitro. Int J Oncol 1993;3:473-6
30. Squatrito R, Connor J, Buller R. Comparison of a novel redox dye cell growth assay to the ATP bioluminescence assay. Gynecol Oncol 1995;58:101-5
31. Hamid R, Rotshteyn Y, Rabadi L, et al. Comparison of alamar blue and MTT assays for high through-put screening. Toxicol In Vitro 2004;18:703-10
32. Collier A, Pritsos C. The mitochondrial uncoupler dicurnerol disrupts the MTT assay. Biochem Pharm 2003;66:281-7
33. Goodwin C, Holt S, Riley P, et al. Growth hormone-responsive DT-diaphorase-mediated bioreduction of tetrazolium salts. Biochem Biophys Res Commun 1996;226:935-41
34. Pagliacci M, Spinozzi F, Migliorati G, et al. Genistein inhibits tumour cell growth in vitro but enhances mitochondrial reduction of tetrazolitun salts: a further pitfall in the use of the MTT assay for evaluating cell growth and survival. Eur J Cancer 1993;29:1573-7
35. Bigll K, Schmitt A, Meiners I, et al. Comparison of results of the CellTiter Blue, the temazolium and the lactate dehydrogenase assay applied in brain cells after exposure to advanced glycation endproducts. Toxicol In Vitro 2007;21:962-71
36. Vistica D, Skehan P, Scudiero D, et al. Tetrazolium-based assays for cellular viability: a critical esamination of selected parameters affecting formazan production. Cancer Res 1991;51:2515-20
37. Plumb J, Milroy R, Kaye S. Effects of pH dependence of 3-(4,5-dimethylthiazol-2-yl)-25-diphenyltetrazolium bromide-formazan absorption on chemosensitivity determined by a novel tetrazolium-based assay. Cancer Res 1989;49:4435-40
38. Crouch S, Kozlowski R, Slater K, et al. The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity. J Immuno Methods 1993;160:81-8
39. Lundin A. Estimation of biomass in growing cell lines by ATP assay. Methods Enzymol 1986;133:27-42
40. White AG, Raju KT, Keddie S, Abouria GM. Lymphocyte activation: changes in intracellular adenosine triphosphate and deoxyribonucleic acid synthesis. Immunol Lett 1989;22:47-50
41. Whitehead T, Kricka L, Carter T, et al. Analytical luminescence: its potential in the clinical laboratory. Clin Chem 1979;25:1531-46
42. Promega Corporation. Method for detection of ATP. US7083911; 2006
43. Hall M, Gruber M, Hannah R, et al. Stabilization of firefly luciferase using directed evolution. In: Roda A, Pazzagli M, Kricka L, et al. editors, Bioluminescence and chemiluminescence - perspectives for the 21st century. John Wiley & Sons: Chichester, UK; 1998. p. 392-5.
44. Severson W, Shindo N, Sosa M, et al. Development and validation of a high-throughput screen for inhibitors of SARS CoV and its application in screening of a 100,000-compound library. J Biomol Screen 2007;12:33-40
45. Borawskii J, Lindeman A, Buxton F, et al. Optimization procedure for small interfering RNA transfection in a 384-well format. J Biomol Screen 2007;12:546-59
46. Park J, Arnaout M, Gupta V. A simple, no-wash cell adhesion-based high throughput assay for the discovery of a small-molecule regulators of the integrin CD11b/CD18. J Biomol Screen 2007;12:406-17
47. 2+ activated photoprotein, Photina®, and its application to high-throughput screening. J Biomol Screen 2007;12:694-704
48. Zhang A, Pastor L, Nguyen Q, et al. Small interfering RNA and gene expresión análisis using a multiplex branched DNA assays without RNA purification. J Biomol Screen 2005;10:549-56
49. Riss T. Selecting cell-based assays for drug discovery screening. Cell Notes 2005;13:16-21
50. Kashem M, Nelson R, Yingling J, et al. Three mechanistically distinct kinase assays compared: measurement of intrinsic ATPase activity identified the most comprehensive set of ITK inhibitors. J Biomol Screen 2007;12:70-83
51. Korzeniewski C, Callewaert D. An enzyme-release assay for natural cytotoxicity. J Immunol Methods 1983;64:211-24
52. Decker T, Lohmann-Matthes M. A quick and simple method for the quantification of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J Immunol Methods 1988;115:61-9
53. Riss T, Moravec R. Introducing the CytoTox-ONE homogeneous membrane integrity assay. Cell Notes 2002;4:6-9
54. Bakshi P, Liao Y-F, Gao J, et al. A high-throughput screen to identify inhibitors of amyloid β-protein precursor processing. J Biomol Screen 2005;10:1-12
55. Herman R, Makeinko M, Prieve M, et al. Phage display screening of epithelial cell monolayers treated with EGTA: identification of pepride FDFWITP that modulates tight junction activity. J Biomol Screen 2007;12:1092-101
56. Pei J, Ficht T. Brucella abortus rough mutants are cytopathic for macrophages in culture. Infect Immun 2004;72:440-50
57. Hasinoff B, Schroeder P, Patel D. The metabolites of the cardioprotective drug dexrazoxane do not protect myocytes from doxorubicin-induced cytotoxicity. Mol Pharmacol 2003;64:67
58. Jackson R, Chandler D, Fulmer J. Production of arachidonic acid metabolites by endothelial cells in hyperoxia. J Appl Physiol 1986;61:584
59. Anderson B, Noble C. In vitro inhibition of lactate dehydrogenases by kepone. J Agric Food Chem 1977;25:8-31
60. Sanders G, van der Neut E, Straalen J. Inhibition of lactate dehydrogenase isoenzymes by sodium perchlorate evaluated. Clin Chem 1990;36:1964-66
61. Lash L, Zalups R. Mercuric chloride-induced cytotoxicity and compensatory hypertrophy in rat kidney proximal tubular cells. J Pharmacol Exp Ther 1992;261:819-29
62. Olsson T, Gulliksson H, Palmeborn M, et al. Leakage of adenylate kinase from stored blood cells. J Appl Biochem 1983;5:437-45
63. Squirrel D, Murphy J. Rapid detection of very low number of micro-organisms using adenylate kinase as a cell marker. A practical guide to industrial uses of ATP luminescence in rapid microbiology. 1997:107-13
64. Corey MJ, et al. A very sensitive coupled luminescent assay for cytotoxicity and complement-mediated lysis. J Immunol Methods 1997;207:43-51
65. Ogbomo H, Hahn A. Geiler J, et al. NK sensitivity of neuroblastoma cells determined by a highly sensitive coupled luminescent method. Biochem Biophys Res Commun 2006;339:375-9
66. Cho M-H, Niles A, Huang R, et al. A bioluminescent cytotoxicity assay for assessment of membrane integrity using a proteolytic biomarker. Toxicol In Vitro 2008;22:1099-106
67. Xing C, LaPorte J, Barbay J. Idendfication of GAPDH as a protein target of the saframycin antiproliferative agents. Proc Natl Acad Sci USA 2004;101:5862-6
68. Du Z-X, Wang H-Q, Zhang H-Y, et al. Involvement of glyceraldehyde-3-phosphate dehydrogenase in tumor necrosis factor-related apoptosis-inducing ligand mediated death of thyroid cancer cells. Endocrinology 2007;148:4352-61
69. Dimmeler S, Ankarcrona M, Nicotera P, et al. Exogenous nitric oxide (NO) generation or IL-1β-induced intracellular NO production stimulates inhibitory auto-ADP-ribosylation of glyceraldehyde-3-phosphate dehydrogenase in RINm5F cells. J Immunol 1993;150:2964-71
70. Ito Y, Pagano K, Tornheim P, et al. Oxidative stress increases glyceraldehyde-3-phosphate dehydrogenase mRNA levels in isolated rabbit aorta. Am J Physiol Heart Circ Physiol 1996;270:H81-7
71. Ranganna K, Yatsu F. Inhibition of platelet-derived growth factor BB-induced expression of glyceraldehyde-3-phosphate dehydrogenase by sodium butyrate in rat vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 1997;17:3420-7
72. Carvajal R, Tse A, Schwartz G. Aurora kinases: new targets for cancer therapy. Clin Cancer Res 2006;12:6869-75
73. Heinrich M, Blanke C, Druker B, et al. Inhibition of KIT tyrosine kinase activity: a novel molecular approach to the treatment of KIT-positive malignancies. J Clin Oncol 2002;20:1692-703
74. Schöffski P, Dumez H, Clement A, et al. Emerging role of tyrosine kinase inhibitors in the treatment of advanced renal cell cancer a review. Ann Oncol 2006;17:1185-96
75. Schmit T, Nihal A. Regulation of mitosis via mitotic kinases: new opportunities for cancer management. Mol Cancer Ther 2007;6:1920-31
76. Niles A, Scurria M, Bernad L, et al. Measure relative numbers of five and dead cells and normalize assay data to cell number. Cell Notes 2007;18:15-20
77. Niles A, Moravec R, Hesselbeth P, et al. A homogeneous assay to measure live and dead cells in the same sample by detecting different protease markers. Anal Biochem 2007;366:197-206
78. Liu J, Bhalgat M, Zhang C, et al. Fluorescent molecular probes V: a sensitive caspase-3 substrate for fluorometric assays. Bioorg Med Chem Lett 1999;9:3231-6
79. Leytus S, Melhado L, Mangel W. Rhodamine-based compounds as fluorogenic substrates for serine proteinases. Biochem J 1983;209:299-307
80. Niles A, Moravec R, Scurria M, et al. MultiTox-fluor multiplex cytotoxicity assay technology. Cell Notes 2006;15:11-5
81. Niles A, Worzela T, Scurria M, et al. Multiplexed viability, cytotoxicity and apoptosis assays for cell-based screening. Cell Notes 2006;16:12-5
82. Niles A, Scurria M, Bernad L, et al. Using protease biomarkers to measure viability and cytotoxicity. Cell Notes 2007;19:16-20
83. Worzella T, Busch M, Niles A. High throughput automation of multiplexed cell viability assays for viability and cytotoxicity. Cell Notes 2008;20:26-9
84. Jones P, King A. High throughput screening (HTS) for phototoxicity hazard using the in vitro 3T3 neutral red uptake assay. Toxicol In Vitro 2003;17:703-8
85. Rose D, Lemmo T. Challenges in implementing high density formats for high throughput screening. Lab Auto News 1997;2:12-9
86. Maffia A, Kariv I, Oldenburg K Miniaturization of a mammalian cell-based assay: luciferase reporter gene readout in a 3 microliter 1536-well plate. J Biomol Screen 1999;4:137-42
87. Maehara Y, Anai H, Tamada R, et al. The ATP assay is more sensitive than the succinate dehydrogenase inhibition test for predicting cell viability. Eur J Cancer Clin Oncol 1987;23:273-6
88. Slater K. Cytotoxicity tests for high-throughput drug discovery. Cur Opin Biotechnol 2001;12:70-4
89. Sanchez-Alcazar J, Ruiz-Cabello J, Hernandez-Munoz I, et al. Tumor necrosis factor-α increases ATP content in metabolically inhibited L929 cells preceding cell death. J Biol Chem 1997;272:30167-77
90. +-ATP synthase, suppresses the TNF-induced apoptosis. Oncogene 2002;21:8149-57
91. Jondeau A, Dahbi I, Bani-Estivals M-H, et al. Evaluation of the sensitivity of three sublethal cytotoxicity assays in human HepG2 cell line using water contaminants. Toxicology 2006;226:218-28
92. Weyermann J, Lochmann D, Zimmer A. A practical note on the use of cytotoxicity assays. Int J Pharm 2005;288:369-76
93. Puttonen K, Lehtonen S, Lampela P, et al. Different viabilities and toxicity types after 6-OHDA and Ara-C exposure evaluated by four assays in five cell lines. Toxicol In Vitro 2008;22:182-9
94. Husoy T, Syversen T, Jenssen J. Comparison of four in vitro cytotoxicity tests: the MTT assay, NR assay, uridine incorporation and protein measurements. Toxicol In Vitro 1993;7:149-54
95. Ulukaya E, Ozdikicioglu F, Yilmaztepe-Oral A, et al. The MTT assay yields a relatively lower result of growth inhibition than the ATP assay depending on the chemotherapeutic drugs tested. Toxicol In Vitro 2008;22:232-9
96. Ausseil F, Samson A, Aussagues Y, et al. High-throughput bioluminescence screening of ubiquitin-proteasome pathway inhibitors from chemical and natural sources. J Biomol Screen 2007;12:106-16
97. Turek-Etienne T, Lei M, Terracciano J, et al. Use of red-shifted dyes in a fluorescence polarization AKT kinase assay for detection of biological activity in natural product extracts. J Biomol Screen 2004;9:52-61
98. O'Brien M, Daily W, Hesselberth E, et al. Homogeneous, bioluminescent protease assays: caspase-3 as a model. J Biomol Screen 2005; 10: 137-48
99. Fan F, Wood K. Bioluminescent assays for high-throughput screening- Assay Drug Dev Technol 2007;5:127-36
100. Cali J, Niles A, Valley M, et al. Bioluminescent assays for ADMET. Expert Opin Drug Metab Toxicol 2008;4:103-20
101. Pratt S, David C, Black-Schaefer C, et al. A strategy for discovery of novel broad-spectrum antibacterials using a high-throughput Streptococcus pneumoniae transcription/translation screen. J Biomol Screen 2004;9:3-11
102. Schröter T, Minond D, Scampavia L, et al. Comparison of miniaturized time-resolved fluorescence resonance energy transfer and enzyme-coupled luciferase high-throughput screening assays to discover inhibitors of Rho-kinase II (ROCK-II). J Biomol Screen 2008;13:17-28
103. Niles A, Moravec R, Riss T. Multiplex caspase activity and cytotoxity assays. Methods Mol Biol 2008;414:151-62
104. Hallis T, Kopp A, Gibson J, et al. An improved β-lactamase reporter assay: multiplexing with a cytotoxicity readout for enhanced accuracy of hit identification. J Biomol Screen 2007;12:635-44
105. Grant S, Sklar J, Cummings R. Development of novel assays for proteolytic enzymes using rhodamine-based fluorogenic substrates. J Biomol Screen 2002;7:531-40
106. Nieuwenhuijsen B, Huang Y, Wang Y, et al. A dual luciferase multiplexed high-throughput screening platform for protein-protein interactions. J Biomol Screen 2003;8:676-84
107. Giuliano K, Haskins J, Taylor D. Advances in high content screening for drug discovery. Assay Drug Dev Technol 2003;1:565-77
108. Abraham V, Taylor D, Haskins J. High content screening applied to large-scale biology. Trends Biotechnol 2004;22:15-22
109. Giuliano K, DeBiasio R, Dunlay R, et al. High-content screening: a new approach to easing key bottlenecks in the drug discovery process. J Biomol Screen 1997;2:249-59
110. Wilson C, Si Y, Thompson C, et al. Identification of a small molecule that induces mitotic arrest using a simplified high-content screening assay and data analysis method. J Biomol Screen 2006;11:21-8
111. Ciambrone G, Liu V, Lin D, et al. Cellular dielectric spectroscopy: a powerful new approach to label-free cellular analysis. J Biomol Screen 2004;9:467-80
112. Zhu J, Wang X, Xu X, et al. Dynamic and label-free monitoring of natural killer cell cytotoxicity using electronic cell sensor arrays. J Immunol Methods 2006;309:25-33
113. Xing J, Zhu L, Gabos S, et al. Microelectric cell sensor assay for detection of cytotoxicity and prediction of acute toxicity. Toxicol In Vitro 2006;20:995-1004
114. i-coupled GPCRs. J Biol Screen 2007;12:312-9
115. Thedinga E, Kob A, Holst H, et al. Online monitoring of cell metabolism for studying pharmacodynamic effects. Toxicol Appl Pharm 2007;220:33-44